EquityFolio

PODD

NASDAQ HEALTHCARE

Insulet Corporation

$148.12

$6.22 (+4.38%)

Live quote

52w: $126.40 – $354.88

Loading chart…
P/E Ratio39.83
P/B Ratio6.92
EV/EBITDA—
Debt/Equity—
ROE17.37%
ROIC—
Revenue Growth30.73%
Gross Margin71.63%
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.

Own PODD? Track it here.

Create a free account to add PODD to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account